Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Selectis Health (GBCS) Shares Outstanding (2017 - 2025)

Selectis Health's Shares Outstanding history spans 13 years, with the latest figure at $3.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $3.1 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $3.1 million (changed 0.0% YoY), and the annual figure for FY2025 was $3.1 million, changed 0.0%.
  • Shares Outstanding for Q4 2025 was $3.1 million at Selectis Health, up from $200500.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $3.1 million in Q2 2024 to a low of $200500.0 in Q1 2021.
  • The 5-year median for Shares Outstanding is $375000.0 (2021), against an average of $1.5 million.
  • The sharpest move saw Shares Outstanding tumbled 93.44% in 2024, then soared 1429.71% in 2025.
  • Year by year, Shares Outstanding stood at $375000.0 in 2021, then soared by 714.56% to $3.1 million in 2022, then increased by 0.41% to $3.1 million in 2023, then changed by 0.0% to $3.1 million in 2024, then changed by 0.0% to $3.1 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $3.1 million, $200500.0, and $3.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.